Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis 12 months [clinicaltrials_resource:fc0be612d91b1fd8328b6b362d09fda5]
The primary efficacy endpoint was the 12 month analysis of primary efficacy failure defined as a composite endpoint including treated biopsy proven acute rejection (BPAR), graft loss, death or loss to follow-up. A treated BPAR episode was defined as a biopsy graded IA, IB, IIA, IIB, or III that was treated with anti-rejection therapy. Graft loss was defined as the allograft was presumed to be lost on the day the patient started dialysis and was not able to subsequently be removed from dialysis as well as re-transplant.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis 12 months [clinicaltrials_resource:fc0be612d91b1fd8328b6b362d09fda5]
The primary efficacy endpoint was the 12 month analysis of primary efficacy failure defined as a composite endpoint including treated biopsy proven acute rejection (BPAR), graft loss, death or loss to follow-up. A treated BPAR episode was defined as a biopsy graded IA, IB, IIA, IIB, or III that was treated with anti-rejection therapy. Graft loss was defined as the allograft was presumed to be lost on the day the patient started dialysis and was not able to subsequently be removed from dialysis as well as re-transplant.
Bio2RDF identifier
fc0be612d91b1fd8328b6b362d09fda5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fc0be612d91b1fd8328b6b362d09fda5
measure [clinicaltrials_vocabulary:measure]
Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis
time frame [clinicaltrials_vocabulary:time-frame]
description
The primary efficacy endpoint ...... ysis as well as re-transplant.
identifier
clinicaltrials_resource:fc0be612d91b1fd8328b6b362d09fda5
title
Number of Participants With Composite Efficacy Endpoints - 12 Month Analysis 12 months
@en
type
label
Number of Participants With Co ...... be612d91b1fd8328b6b362d09fda5]
@en